Holman RR, Bethel MA, Mentz RJ, Thompson VP, Lokhnygina Y, Buse JB, Chan JC, Choi J, Gustavson SM, Iqbal N, Maggioni AP, Marso SP, Öhman P, Pagidipati NJ, Poulter N, Ramachandran A, Zinman B, Hernandez AF, for the EXSCEL Study Group.
Effects of once-weekly exenatide on cardiovascular outcomes in type 2 diabetes.
N Engl J Med 2017;377:28 de septiembre. [Ref.ID 102096]